United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - kalligatm tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with kalligatm , 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. emergency contraceptive pills: treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.§ lactation amenorrhea method: lam is

United States - English - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - oral contraceptives should not be used in women who currently have the following conditions:

United States - English - NLM (National Library of Medicine)

par pharmaceutical - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - kimidess® is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states.    % of women experiencing an unintended pregnancy within the first year of use   % of women continuing use at one year 3 adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience

United States - English - NLM (National Library of Medicine)

prasco laboratories - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (estradiol - unii:4ti98z838e) - kit - 0.1 mg - cesia® (desogestrel/ethinyl estradiol) tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and implants, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease (current or history) - valvular heart disease with thrombogenic complications - severe hypertension - diabetes with vascular involvement - headaches with focal neurological symptoms - major surgery w

Canada - English - Health Canada

aspen pharmacare canada inc. - desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol - tablet - 0.1mg; 0.025mg; 0.125mg; 0.025mg; 0.15mg; 0.025mg - desogestrel 0.1mg; ethinyl estradiol 0.025mg; desogestrel 0.125mg; ethinyl estradiol 0.025mg; desogestrel 0.15mg; ethinyl estradiol 0.025mg - contraceptives

Canada - English - Health Canada

aspen pharmacare canada inc. - desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol - tablet - 0.1mg; 0.025mg; 0.125mg; 0.025mg; 0.15mg; 0.025mg - desogestrel 0.1mg; ethinyl estradiol 0.025mg; desogestrel 0.125mg; ethinyl estradiol 0.025mg; desogestrel 0.15mg; ethinyl estradiol 0.025mg - contraceptives

United States - English - NLM (National Library of Medicine)

aspen global inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.1 mg

United States - English - NLM (National Library of Medicine)

organon usa inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.1 mg

United States - English - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

United States - English - NLM (National Library of Medicine)

watson pharma, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg